Episoder
-
This episode features Dave Rosa, CEO of NeuroOne, a company leading the way in innovative solutions for various neurological disorders. The discussion highlights the significant challenges faced by patients with epilepsy, particularly those whose condition is resistant to medication. Traditional treatment often involves multiple invasive surgeries, placing a significant physical and emotional burden on patients.
NeuroOne has developed a groundbreaking technology that integrates both diagnostic and therapeutic functions into a single device. This innovative approach enables physicians to identify the source of seizures and then immediately proceed with ablation of the affected brain tissue within a single surgical procedure, minimizing patient discomfort and hospital stays.
We explore the strategic partnership with Zimmer Biomet that has been pivotal for NeuroOne's successful market access, helping accelerate commercialization. With additional data insights, and future pharma collaboration opportunities, the future is truly bright for Dave and the team. NeuroOne is helping advance the movement towards personalized medicine, offering hope for improved patient outcomes, a story sure to leave you informed and inspired.
-
Novosound is a pioneering company in the field of ultrasound technology, with a mission to revolutionize the way we monitor vital signs. Traditional blood pressure monitoring methods, often involving bulky cuffs and infrequent measurements, can be inconvenient and provide limited insights. Novosound aims to address these limitations through their innovative, non-invasive, and continuous blood pressure monitoring solution.
By leveraging advanced thin-film ultrasound technology, Novosound's sensors can be integrated into wearable devices, making it possible to track blood pressure in real-time. This continuous monitoring can provide valuable information to both patients and healthcare providers, enabling early detection of potential health issues and more effective management of conditions like hypertension.
In this episode, we delve deeper into the technology behind Novosound's innovations. Dave Hughes, CEO and founder of Novosound, discusses the academic research foundation of the technology, along with the exciting potential for partners to leverage new capabilities with their wearable application. Dave details the company's strategy for a future where continuous, non-invasive monitoring becomes the norm, a story sure to leave you informed and inspired.
-
Manglende episoder?
-
IntelVasc is a medical technology company focused on addressing the significant issue of peripheral arterial disease (PAD). This condition, often undiagnosed, can lead to serious complications like heart attacks and strokes. CEO & co-founder, Andrew Ortega-Verdaguer, joins this episode to discuss how he plans to lead the business from visionary prototype through to market as the team gears up for first FDA discussions early next year.
The company's innovative solution involves a minimally invasive sensor, inserted subcutaneously near to the femoral artery. This sensor, paired with a portable scanner, will enable patients to monitor their vascular health at home. By collecting real-time data on blood flow, the technology can empower patients and clinicians to proactively identify potential issues and intervene early, reducing the risk of major complications.
IntelVasc's technology has the potential to revolutionize the management of PAD. By providing a convenient and reliable method for monitoring vascular health, the company aims to improve patient outcomes, reduce healthcare costs, and enhance the overall quality of life for individuals with this condition. With additional AI and ML opportunities, this is an exciting medtech story sure to keep you informed and inspired.
-
Epilepsy is a neurological disorder affecting millions worldwide, significantly impacting the quality of life of both patients and their loved ones. Traditional management usually relies heavily on medication, which can have severe side effects. Despite the high prevalence of the condition, there is still a lack of objective data on seizure activity.
EpiWatch CEO, Teresa Prego, joins this episode to discuss their wearable device designed to detect and alert for tonic-clonic seizures. By leveraging Apple Watch technology, EpiWatch provides real-time seizure detection and can alert caregivers, potentially reducing the risk of injury and improving response times. The device also collects valuable data on seizure patterns, enabling clinicians to make more informed treatment decisions.
By partnering with clinicians, pharmaceutical companies, and device manufacturers, EpiWatch can integrate seamlessly with existing healthcare solutions, helping contribute to a broader ecosystem of epilepsy management. With FDA clearance anticipated in 2025, EpiWatch has the potential to revolutionize the way epilepsy is managed, improving the lives of patients and their families, a mission sure to leave you informed and inspired.
-
Bimal Maharjan, CEO & founder of GutSphere, joins the podcast to discuss the company's mission to empower patients with gastrointestinal (GI) issues. Bimal shares his personal journey with chronic GI conditions, highlighting the challenges patients face, such as embarrassment, lack of education, and difficulty navigating the healthcare system.
GutSphere aims to address these challenges by providing a patient-centric platform that offers personalized education, symptom tracking, and community support. The platform leverages AI technology to provide tailored insights and a user-friendly experience. By combining technology with a deep understanding of patient needs, GutSphere has the potential to revolutionize GI care and improve the lives of millions of people.
As GutSphere is currently in development, the team is focused on building a minimum viable product and gathering user feedback to refine the platform. Tune in so you can learn about Bimal’s gut health mission and how to join the GutSphere community to help build a better solution for all patients to improve their gut health. This is a patient-centric story sure to leave you informed and inspired.
-
In this episode, we delve into the world of AI-powered healthcare with Shayan Mashatian, the founder of Pingoo.AI. You can learn how this innovative startup is applying AI to tackle a critical healthcare challenge: diabetic foot ulcers.
Shayan highlights the alarming statistics surrounding diabetes and its complications, emphasizing the need for greatly improved patient education and engagement. Pingoo.AI's solution leverages AI to provide personalized education and support for patients, helping them understand their condition and manage it effectively.
Shayan also shares how collaboration between healthcare providers, innovators, and patients, is leading to better AI integration and use of data. By leveraging technology and fostering a community-driven approach, the Pingoo.AI team is working towards a future where diabetes and its complications are better managed and ultimately prevented, a mission sure to leave you informed and inspired.
-
Novobeing is addressing a significant problem in healthcare: poor patient experience during hospital stays. Their solution involves using virtual reality technology to transport patients to calming environments, helping to reduce stress and anxiety. Beyond the direct benefits to patients, this also aims to improve HCAHPS (Hospital Consumer Assessment of Healthcare Providers and Systems) scores, as patient satisfaction increases.
CEO and co-founder, Sid Desai, shares how their research studies are validating these benefits for hospitals systems, with exciting recent results from Massachusetts General Hospital providing further evidence. The company's initial focus is on patients undergoing stem cell transplant procedures, who often face prolonged hospital stays and isolation. Novobeing’s VR technology offers a way to improve their mental well-being and overall experience.
With several hospital systems already testing Novobeing’s solution, Sid discusses the exciting opportunities, including the potential to reduce pharmacological interventions. As the healthcare industry embraces Medical VR, the vision of fully patient-centered care comes closer to reality. Novobeing is well placed to play a central role in this evolution, meaning this story is sure to leave you informed and inspired.
-
Prapela is a medical device company focused on improving newborn health. Their primary product is a specially designed mattress that uses gentle vibrations to regulate infant breathing, particularly for babies experiencing apnea of prematurity and neonatal opioid withdrawal syndrome.
CEO & co-founder, John Konsin, joins this episode to share how many newborns, especially premature babies, experience breathing irregularities, including apnea and oxygen desaturation. Prapela's innovative mattress offers a non-invasive solution than can reduce the need for additional interventions while lowering costs for hospitals.
Prapela's market potential is significant, as it addresses a common and serious issue affecting newborn infants. Building on decades of research and recent exciting clinical evidence, the Prapela journey is definitely one to track, be sure to tune in so you can be informed and inspired.
-
Millions of men suffer from premature (early) ejaculation, the most common sexual disorder in men younger than 40 years, with 30-70% of males in the United States affected to some degree at one time or another. This can be a major relationship issue for both partners and is often viewed as a challenging matter to discuss. Coupled with this, existing treatments like sprays, creams, and antidepressants have side effects or are found to be not very effective.
Morari Medical’s CEO and Founder, Jeff Bennett, joins this episode to share how they are developing a wearable patch that uses neurostimulation to delay ejaculation. The patch is placed on the perineum, the area between the scrotum and the anus, and users can control the settings through an app to find what works best for them.
As Morari gears up for FDA approval and aims to be on the market in early 2025, Jeff discusses how he has transitioned from working at Boston Scientific to leading not just a startup, but a movement to make premature ejaculation no longer a taboo topic. From being spotlighted on Jimmy Kimmel, to winning numerous accolades, Jeff’s story will be sure to leave you informed and inspired.
-
For episode 60, and one of the most popular recordings to date, we re-release the very first episode of the show where Rajit Kamal, currently VP & General Manager of Medtronic's Surgical Robotics division, joined us to talk about early-stage innovation.
This is a must listen for any medtech entrepreneur as Rajit discusses how large medtech companies approach innovation and what they look for in early-stage startups.
Rajit shares insights from his years of experience in the industry, developing winning teams, and how to overcome challenges bringing new solutions to patients. Be sure to tune in so you can be informed and inspired.
-
Jhonatan Bringas Dimitriades MD, CEO and co-founder of Lapsi Health, joins this episode to share insights into the company's newly launched product, Keikku—a revolutionary digital stethoscope designed to enhance the detection and monitoring of health conditions through advanced acoustic processing. Jhonatan discusses how Keikku is transforming traditional stethoscopes from simple listening devices into powerful data-driven tools that support medical diagnosis and patient monitoring.
Initially targeting general healthcare professionals, Keikku is a part of Lapsi's broader vision to revolutionize health tracking. The stethoscope allows healthcare professionals to stream real-time sound clips and communicate securely, enabling faster and more accurate medical insights. Future software updates will incorporate AI-driven analysis for heart murmur detection and respiratory issues like wheezing, positioning Keikku at the forefront of smart medical devices.
Throughout the discussion, Jhonatan emphasizes Lapsi Health's mission to make cutting-edge medtech more accessible and user-friendly for healthcare professionals and patients alike. With FDA clearance for Keikku already secured and additional approvals for AI features in the pipeline, the Lapsi team has a clear vision to position their hardware and software platform to help reshape how doctors and patients engage with medical technology. Listen in so you can be informed and inspired.
-
When you’re talking to one the founding fathers of pulse field ablation, you know you’re in for a real whirlwind of wisdom. Dr. Steven Mickelsen is a board-certified electrophysiologist who invented a pulsed electric field system and founded FARAPULSE in 2012. Ten years later, he is back at it again, with the founding of Field Medical Inc., as he looks to continue the crusade for superior cardiac ablation procedures.
This discussion delves deep into the anatomical anomalies that ablation looks to tackle. Steven masterfully guides through the depths of the heart’s chambers and the limitations of today’s techniques. Through reverse engineering the problem, Field Medical is bringing new possibilities to tackling the underserved space of ventricular arrhythmia ablation.
From the outset, Steven’s knowledge makes this a truly insightful summary of all things pulsed field ablation related, with a good sprinkling of entrepreneurial sagacity. Nearly every innovative startup hones in on a true unmet need to get started, and Field Medical’s blue ocean opportunity in VT makes this episode one that will be sure to leave you informed and inspired.
-
Kristin Nuckols, co-Founder & Chief Clinical Officer of Imago Rehab, joins this episode to discuss the challenges and opportunities in stroke rehabilitation. She highlights the increasing incidence of stroke and the devastating impact it can have on survivors and their families. She shares the challenges faced by healthcare providers in delivering effective post-stroke care, particularly in resource-limited settings.
Kristin provides insights into her extensive experience as an Occupational Therapist and time in the Harvard Biodesign program that has allowed her to build a unique understanding of how high-quality rehabilitation for stroke survivors can improve their physical, cognitive, and emotional outcomes. Despite the numerous benefits of rehab, the growing number of patients mean new flexible solutions are essential to ensure the right care is available.
Imago Rehab is developing innovative solutions to address these challenges, with a focus on making high-quality rehabilitation accessible to anyone recovering from a stroke. If you want to learn how soft robotics is being coupled with telemedicine to build a better future, then tune so you can be informed and inspired.
-
Millions of patients develop pressure injuries (bed sores) every year, often due to a lack of early detection. These wounds can lead to serious complications and even death. The current method of diagnosis relies on visual inspection by healthcare providers, which can be subjective and unreliable.
Sanna Gaspard, CEO & Founder of Rubitection, joins this episode to discuss how she is developing a low-cost, easy-to-use medical device that uses optics to measure skin redness and inflammation, providing objective data for early detection of pressure injuries. The device is accompanied by a mobile app that allows clinicians to track changes in the wound, receive care recommendations, and capture images.
Sanna shares insights around Rubitection’s functional prototype that has shown positive results in initial human testing. Access is a key word throughout the episode, and this includes how the company is utilizing Wefunder to crowdfund the capital needed to advance the technology and ensure that the community can access investing in the venture. Packed with impactful goals for patients, this story is sure to leave you informed and inspired.
Be sure to join us on September 25-26 at MEDevice Boston where you can hear from other innovators leading the charge to help improve patient lives (use the code IMPACT to get your free expo pass and 20% conference ticket discount at the checkout).
-
Augie Shanahan, CEO of Piccolo Medical, joins this episode to discuss the challenges and opportunities in the field of central venous catheter placement. He highlights the limitations of current Peripherally inserted central catheter (PICC) technologies and the need for more accurate and reliable navigation methods.
Piccolo Medical is developing innovative solutions to address these challenges, including their proprietary ionic dilution technology that provides real-time blood flow visualization. This technology has the potential to improve the accuracy and safety of catheter placement, especially in patients with arrhythmias.
Augie shares insights into the company's journey, from its origins as a spin-out from the TheraNova incubator to its recent FDA clearance for the Easy Guide Connector. As an engineer turned CEO, Augie has plenty of great perspectives of the numerous challenges in successfully developing a novel medical, insights sure to leave you informed and inspired.
Be sure to join us on September 25-26 at MEDevice Boston where you can hear from other innovators leading the charge to help improve patient lives (use the code IMPACT to get your free expo pass and 20% conference ticket discount at the checkout).
-
Chris Landon, CEO of Natus Neuro, joins us to discuss the challenges and opportunities in neurodiagnostics. Six months since being appointed, Chris shares a clear vision for Natus as he explains the need for improved access to diagnostic tools and the importance of data-driven insights for better patient care.
Chris emphasizes the role of technology in addressing these challenges, including artificial intelligence and cloud-based solutions. A focus on patient-centric innovation is a recurring theme throughout the episode as Chris details their commitment to developing solutions that improve clinical workflows and patient outcomes.
From winning principles in product development, to developing a global strategy with a new team, this conversation is a fantastic insight into how Chris is leading the Natus vision. If you want to learn about the latest neuro sensor trends, and how to execute a winning game plan to address these, then be sure to tune in so you can be informed and inspired.
Be sure to join us on September 25-26 at MEDevice Boston where you can hear from other innovators leading the charge to help improve patient lives (use the code IMPACT to get your free expo pass and 20% conference ticket discount at the checkout).
-
Sydney Robinson, CEO & co-founder of Vessl Prosthetics, joins this episode to discuss how they are enhancing prosthetic technology. Her innovative company is developing an advanced prosthetic socket that can offer unparalleled comfort, mobility, and functionality for amputees.
During the discussion, Sydney shares her personal journey and the critical medical innovation fellowship that led to the founding of Vessl Prosthetics. She discusses the challenges faced by amputees and the limitations of traditional prosthetic solutions. Vessl's mission is to address these shortfalls by providing truly accessible and customized solutions that improve the quality of life for users.
We dive into the company's research and development efforts to reach these goals, including collaborating with Stevie Crawford as he trains for the 2026 Winter Paralympics. Sydney also shares insights into the latest advancements in prosthetic technology and the potential for future partnerships. As the company prepares for FDA approval, strap in and listen, so you can be informed and inspired.
Be sure to join us on September 25-26 at MEDevice Boston where you can hear from other innovators leading the charge to help improve patient lives (use the code IMPACT to get your free expo pass and 20% conference ticket discount at the checkout).
-
SmartCardia is a medical technology company developing innovative solutions to improve cardiac care. The company's flagship product is a 7-lead ECG patch that collects vital signs and enables remote patient monitoring. This technology addresses the limitations of traditional ECG patches by providing more comprehensive data and facilitating real-time monitoring.
Adam Kirchgessner, VP of Sales at SmartCardia, joins this episode to discuss the company's mission and technology. He highlights how they are helping provide accurate and accessible cardiac data for early detection and diagnosis of arrhythmias and other heart conditions. Adam also explains the significant value prop of their advanced platform that enables seamless data integration and analysis, empowering healthcare providers to make informed decisions.
Beyond ECG monitoring, the company's goal is to become a comprehensive cardiac care solution, offering remote patient monitoring for conditions like heart failure and sleep apnea. Adam delves into what goes into building a winning sales team to achieve these ambitions, touching on his extended experience with other innovative technologies. Whatever your position in the medical technology space, this episode is packed with insights on delivering great innovation, a discussion sure to leave you informed and inspired.
Be sure to join us on September 25-26 at MEDevice Boston where you can hear from other innovators leading the charge to help improve patient lives (use the code IMPACT to get your free expo pass and 20% conference ticket discount at the checkout).
-
For our 50th episode, we are joined by Mike Hugo, a patient advocate for Medtronic, who shares the story behind his battle with glioblastoma, a highly aggressive form of brain cancer. Mike's unique perspective as both a patient and industry insider offer valuable insights into the challenges and triumphs of navigating a complex medical condition.
The discussion delves into Mike's journey, from initial diagnosis to experiences with a unique treatment pathway, and the impact of Novocure's incredible Optune technology that he wears every day. Mike's unwavering determination and positive outlook shine through as he explains his advocacy efforts, including supporting the Promising Pathway Act, to improve access to these types of advanced treatments for other patients.
Beyond his personal story, Mike offers valuable insights into the medtech industry, sharing former experiences as a medtech sales professional and his passion for driving innovation in patient care. His firsthand knowledge of medical devices and advocacy work with his wife Vanessa, highlight the importance of collaboration between patients, healthcare providers, and industry leaders in advancing healthcare solutions. Listen in, and be prepared, to be truly, inspired and informed.
Be sure to join us on September 25-26 at MEDevice Boston where you can hear from other innovators leading the charge to help improve patient lives (use the code IMPACT to get your 20% discount at the checkout).
-
After a needlestick injury, Dr. William Travis Lau conceived a safety suturing device to protect other healthcare workers from suffering a similar incident. Partnering with Joe Lane to help create what would become SafePath Medical, they started development of the first safety suturing device for catheter securement. Though Travis tragically passed away in 2019, his legacy endures through this life-saving innovation and his contributions to patient safety and blood management practices.
SafePath’s CEO Joe, joins this episode to share insights into the unique design challenges that have been overcome to realize Travis’s vision, and create an ergonomic device that is capable of safe suturing for catheter securement and skin closure. With FDA clearance already in place for the intended use in placement of a silk suture in the skin and subcutaneous tissues, Joe discusses the multiple benefits that can now be made available to healthcare workers.
This physician-backed solution is packed with engineering ingenuity and Joe shares how M2D2 is entwined in the backstory that helped the startup move from prototype to marketplace, leaving it primed to revamp the current standard of care. Under Joe’s leadership, SafePath Medical is realizing not only Travis’s vision, but a safer future for frontline healthcare workers. This is a true legacy story that is sure to leave you informed and inspired.
- Vis mere
